{
    "organizations": [],
    "uuid": "6900ada2db27b76c0c5593504f4e95f58079244e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ionis-pharmaceuticals-reports-q4-e/brief-ionis-pharmaceuticals-reports-q4-earnings-per-share-of-0-02-idUSASB0C7O5",
    "ord_in_thread": 0,
    "title": "BRIEF-Ionis Pharmaceuticals Reports Q4 Earnings Per Share of $0.02‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Ionis Pharmaceuticals Inc:\n* IONIS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 REVENUE $172.3 MILLION * Q4 EARNINGS PER SHARE $0.02‍​ * Q4 EARNINGS PER SHARE VIEW $0.01, REVENUE VIEW $124.7 MILLION -- THOMSON REUTERS I/B/E/S\n* IONIS PHARMACEUTICALS-‍AS OF DEC 31, 2017, HAD CASH, CASH EQUIVALENTS & SHORT-TERM INVESTMENTS OF MORE THAN $1 BILLION COMPARED TO $665 MILLION AT DEC 31, 2016​\n* IONIS PHARMACEUTICALS - ‍CASH BALANCE AT DEC 31, 2017 INCLUDED PROCEEDS FROM AKCEA‘S 2017 IPO AND NOVARTIS’ INVESTMENT IN AKCEA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T20:14:00.000+02:00",
    "crawled": "2018-02-28T12:53:28.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "ionis",
        "pharmaceutical",
        "inc",
        "ionis",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "revenue",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "ionis",
        "dec",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "billion",
        "compared",
        "million",
        "dec",
        "ionis",
        "pharmaceutical",
        "balance",
        "dec",
        "included",
        "proceeds",
        "akcea",
        "ipo",
        "novartis",
        "investment",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}